UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

Molecular cancer therapeutics, 2009-12, Vol.8 (12), p.3341-3349

2009

Volltextzugriff (PDF)

Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in rats

Journal of pharmacological and toxicological methods, 2016-03, Vol.78, p.32-41

2016

Volltextzugriff (PDF)

Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events

Molecular and cellular endocrinology, 2011-06, Vol.339 (1-2), p.72-80

2011

Volltextzugriff (PDF)

Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development

Cancer research (Chicago, Ill.), 2002-05, Vol.62 (9), p.2516-2521

2002

Volltextzugriff (PDF)

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and Wap-ras transgenic mice

Cancer research (Chicago, Ill.), 1998-11, Vol.58 (21), p.4947-4956

1998

Volltextzugriff (PDF)

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer

Clinical cancer research, 1998-04, Vol.4 (4), p.835-846

1998

Volltextzugriff (PDF)

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

Cancer chemotherapy and pharmacology, 1999, Vol.44 (2), p.143-151

1999

Volltextzugriff (PDF)

Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (16), p.6522-6530

2009

Volltextzugriff (PDF)

Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

ACS medicinal chemistry letters, 2015-08, Vol.6 (8), p.908-912

2015

Volltextzugriff (PDF)

Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts

Cancer gene therapy, 1997-03, Vol.4 (2), p.129-138

1997

Volltextzugriff (PDF)

Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models

Human gene therapy, 1998-03, Vol.9 (5), p.681-694

1998

Volltextzugriff (PDF)

Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.02,6]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (15), p.4491-4495

2010

Volltextzugriff (PDF)

Structure−Activity Relationship of 3-Substituted N-(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor Compounds

Journal of medicinal chemistry, 1997-12, Vol.40 (26), p.4290-4301

1997

Volltextzugriff (PDF)

Abstract 5782: Androgen receptor antagonists: Lead optimization and preclinical pharmacology

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5782-5782

2010

Volltextzugriff (PDF)

Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.02,6]undec4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (15), p.4491-4495

2010

Volltextzugriff (PDF)

Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.50-58

1999

Volltextzugriff (PDF)

Polanyi, Piketty, and the Twenty-First Century Market Economy

Journal of economic issues, 2024-01, Vol.58 (1), p.1-12

2024

Volltextzugriff (PDF)

Who are the Real Top Dogs and the Real Underdogs?

Journal of economic issues, 2022-10, Vol.56 (4), p.988-1005

2022

Volltextzugriff (PDF)

Outcomes of a controlled trial with visiting therapy dog teams on pain in adults in an emergency department

PloS one, 2022-03, Vol.17 (3), p.e0262599-e0262599

2022

Volltextzugriff (PDF)

Dualistic Discourse and Immigration Policy

Journal of economic issues, 2020-01, Vol.54 (1), p.38-53

2020

Volltextzugriff (PDF)

Stillbirths: recall to action in high-income countries

The Lancet (British edition), 2016-02, Vol.387 (10019), p.691-702

2016

Volltextzugriff (PDF)

Contingent Labor and Higher Education

Review of political economy, 2017-04, Vol.29 (2), p.232-248

2017

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in rats

Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events

Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and Wap-ras transgenic mice

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer

Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts

Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models

Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity

Discovery of a 1 H -Benzoimidazol-2-yl)-1 H -pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.02,6]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists

Structure−Activity Relationship of 3-Substituted N-(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor Compounds

Abstract 5782: Androgen receptor antagonists: Lead optimization and preclinical pharmacology

Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.02,6]undec4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists

Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

Polanyi, Piketty, and the Twenty-First Century Market Economy

Who are the Real Top Dogs and the Real Underdogs?

Outcomes of a controlled trial with visiting therapy dog teams on pain in adults in an emergency department

Dualistic Discourse and Immigration Policy

Stillbirths: recall to action in high-income countries

Contingent Labor and Higher Education

Suchergebnisse filtern